MYGN 28.47 (-0.45%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

44 / 57

Dividend yield

0 / 8

Total Cash

36 / 57

Performance 3 years

17 / 58

Performance 5 years

28 / 58

Performance 10 years

32 / 58

Linearity 3 years

16 / 58

Linearity 5 years

4 / 58

Linearity 10 years

9 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Earnings per Share - MYGN ranking 44 / 57

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
36.4
2. Thermo Fisher Scientific TMO
16.09
3. Medpace Holdings MEDP
10.63
4. IDEXX Laboratories IDXX
10.09
5. Waters WAT
10.02
6. Icon ICLR
8.61
7. Charles River Laboratories CRL
8.36
8. IQVIA Holdings IQV
7.7
9. Quest Diagnostics DGX
7.41
10. Lantheus Holdings LNTH
6.09
11. Danaher DHR
5.45
12. Laboratory Corp of America Holdings LH
5.37
13. Agilent Technologies A
4.81
14. PerkinElmer PKI
2.78
15. DexCom DXCM
1.61
16. National Research NRC
1.19
17. Syneos Health SYNH
0.7
18. Interpace Biosciences IDXG
0.68
19. Global Cord Blood CO
0.59
20. Qiagen QGEN
0.35
21. RadNet RDNT
0.18
22. Sotera Health SHC
0.14
23. Ortho Clinical Diagnostics Holdings OCDX
0
24. Neogen NEOG
-0.04
25. Olink Holding OLK
-0.27
26. MaxCyte MXCT
-0.34
27. Enzo Biochem ENZ
-0.35
28. Anixa Biosciences ANIX
-0.39
29. Biodesix BDSX
-0.45
30. NeoGenomics NEO
-0.62
31. Bioventus BVS
-0.65
32. Psychemedics PMD
-0.79
33. Neuronetics STIM
-0.89
34. bioAffinity Technologies BIAF
-0.91
35. Exact Sciences EXAS
-0.95
36. Exagen XGN
-0.97
37. Sera Prognostics SERA
-0.98
38. Co-Diagnostics CODX
-1.26
39. Aspira Womens Health AWH
-1.41
40. MDxHealth MDXH
-1.48
41. Pacific Biosciences of California PACB
-1.5
42. Personalis PSNL
-1.64
43. DarioHealth DRIO
-1.68
44. Myriad Genetics MYGN
-1.77
45. Heska HSKA
-1.92
46. Organovo Holdings ONVO
-2.16
47. Precipio PRPO
-2.29
48. Natera NTRA
-2.44
49. Trinity Biotech TRIB
-2.67
50. CareDx CDNA
-2.98
51. Twist Bioscience TWST
-3.82
52. Inotiv NOTV
-3.84
53. Guardant Health GH
-4.11
54. Prenetics Global PRE
-4.28
55. Fulgent Genetics FLGT
-5.47
56. SeqLL SQL
-16.4
57. Illumina ILMN
-19.16
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.